Your browser doesn't support javascript.
loading
Phytochemical Profile, Antioxidant, Anti-Atopic, and Anti-Inflammatory Activities of Filipendula glaberrima Nakai at Different Growth Stages.
Lee, Hak-Dong; Tonog, Genevieve; Uy, Neil Patrick; Lee, Yunji; Kim, Ki-Young; Kim, Hangeun; Lee, Sanghyun.
Affiliation
  • Lee HD; Department of Plant Science and Technology, Chung-Ang University, Anseong 17546, Republic of Korea.
  • Tonog G; Natural Product Institute of Science and Technology, Anseong 17546, Republic of Korea.
  • Uy NP; Department of Food and Nutrition, Chung-Ang University, Anseong 17546, Republic of Korea.
  • Lee Y; Department of Plant Science and Technology, Chung-Ang University, Anseong 17546, Republic of Korea.
  • Kim KY; Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, Eumseong 27709, Republic of Korea.
  • Kim H; Department of Genetics and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.
  • Lee S; Research and Development Center, Skin Biotechnology Center Inc., Yongin 17104, Republic of Korea.
Pharmaceuticals (Basel) ; 17(7)2024 Jul 11.
Article in En | MEDLINE | ID: mdl-39065778
ABSTRACT
Since atopic dermatitis is an inflammatory skin disease, natural remedies, such as Filipendula glaberrima Nakai (FG), with anti-inflammatory properties are possible promising therapeutic options. This study aimed to investigate the therapeutic potential of FG extracts at different growth stages. Seven compounds were isolated from the FG leaf extracts using open-column chromatography, and they were analyzed using HPLC. The extracts were further evaluated for their total polyphenol and flavonoid content (TPC and TFC). The in vitro antioxidant properties of the FG extracts were evaluated using radical scavenging assays, whereas their anti-inflammatory activities were assessed by evaluating their ability to inhibit the production of inflammation-associated biomarkers using the Griess assay and ELISA, respectively. The MTT assay was used to evaluate the viability and cytotoxicity of the FG extracts in keratinocyte cell lines. The results showed that the full-flowering stage exhibited the highest TPC, TFC, and antioxidant activities, thus suggesting a positive correlation between these properties. All FG extracts showed significant anti-inflammatory activity by inhibiting the production of pro-inflammatory biomarkers in lipopolysaccharide-stimulated macrophages. Additionally, the FG extracts suppressed the production of cytokines and chemokines in keratinocytes, indicating their anti-atopic potential. HPLC analysis revealed that the full-flowering stage had the highest content of all the analyzed phytochemicals (gallic acid, (+)-catechin, hyperin, miquelianin, astragalin, afzelin, and quercetin). These results suggest that the full-flowering stage of FG is the most promising source for therapeutic applications owing to its superior phytochemical profile and biological activities. This study highlights the potential of FG extracts, particularly in its full-flowering stage, as a natural therapeutic agent for the management of inflammation-related diseases, and it can also serve as a reference for further research on FG.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2024 Document type: Article Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2024 Document type: Article Country of publication: Switzerland